Veliparib added to chemotherapy, continued as maintenance tx prolongs progression-free survival.
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors.
Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.
Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.
Survivors of NHL should be offered genetic counseling.